Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

BioGaia

106,3

 

SEK

 

+0,76 %

Mindre end 1K følgere

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Sammenligne
+0,76%
+4,73%
-17,21%
-5%
+1,82%
-20,97%
+5,88%
+10,38%
+1.396,49%

BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.

Læs mere
Markedsværdi
10,75 mia. SEK
Aktieomsætning
5,28 mio. SEK
Omsætning
1,42 mia.
EBIT %
29,76 %
P/E
30,55
Udbytteafkast, %
6,49 %
Finanskalender
18.7
2025

Delårsrapport Q2'25

22.10
2025

Delårsrapport Q3'25

Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse7.5.2025, 16.30

Annual General Meeting of BioGaia

BioGaia
BioGaia, Audiocast with teleconference, Q1'25
Videopræsentation7.5.2025, 07.30

BioGaia, Audiocast with teleconference, Q1'25

BioGaia
Selskabsmeddelelse7.5.2025, 06.00

BioGaia AB: Interim Management Statement January - March 2025

BioGaia

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse2.4.2025, 08.30

Notice to attend the Annual General Meeting of BioGaia AB (publ)

BioGaia
Selskabsmeddelelse26.3.2025, 10.00

BioGaia Annual and Sustainability Report 2024 published

BioGaia
Selskabsmeddelelse20.3.2025, 20.30

Transition in BioGaia: Anatom Holding, a Switzerland-based long-term investment firm, becomes anchor shareholder

BioGaia
BioGaia, Audiocast with teleconference, Q4'24
Videopræsentation12.2.2025, 08.30

BioGaia, Audiocast with teleconference, Q4'24

BioGaia
Selskabsmeddelelse12.2.2025, 07.00

BioGaia AB: Year-end report January - December 2024

BioGaia
Selskabsmeddelelse4.2.2025, 07.00

BioGaia's results for the fourth quarter to exceed market expectations

BioGaia
Pressemeddelelse5.12.2024, 13.00

BioGaia launches a new probiotic supplement, BioGaia® Gastrus® PURE ACTION, designed for people with sensitive digestive systems

BioGaia
BioGaia, Audiocast with teleconference, Q3'24
Videopræsentation22.10.2024, 07.30

BioGaia, Audiocast with teleconference, Q3'24

BioGaia
Selskabsmeddelelse22.10.2024, 06.00

BioGaia AB: Interim Management Statement January - September 2024

BioGaia
Selskabsmeddelelse17.10.2024, 20.00

BioGaia's preliminary results for the third quarter did not reach market expectations

BioGaia
Selskabsmeddelelse30.9.2024, 09.00

Change in the number of shares and votes in BioGaia AB (publ)

BioGaia
Selskabsmeddelelse30.8.2024, 09.00

Change in the number of shares and votes in BioGaia AB (publ)

BioGaia
Selskabsmeddelelse31.7.2024, 09.00

Change in the number of shares and votes in BioGaia AB (publ)

BioGaia
BioGaia, Audiocast with teleconference, Q2'24
Videopræsentation23.7.2024, 07.30

BioGaia, Audiocast with teleconference, Q2'24

BioGaia
Selskabsmeddelelse23.7.2024, 06.00

BioGaia AB: Interim Management Statement January - June 2024

BioGaia
Selskabsmeddelelse7.5.2024, 15.30

Annual General Meeting of BioGaia

BioGaia
BioGaia, Audiocast with teleconference, Q1'24
Videopræsentation7.5.2024, 07.30

BioGaia, Audiocast with teleconference, Q1'24

BioGaia
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.